The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells presents a paramount challenge for the biopharmaceutical industry. Multiple strategies can be employed enhance antibody titer, such as process parameter optimization, genetic engineering, and the use of perfusion systems. Fine-tuning culture conditions play